EUPRAXIA PHARMACEUTICALS INC. Operating Expenses
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Operating Expenses of $38.43 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-03-13
| Period end | Operating Expenses 12 month |
|---|---|
| 2025-12-31 | $38.43M 40-F · filed 2026-03-13 |
| 2024-12-31 | $27.00M 40-F · filed 2026-03-13 |
| 2023-12-31 | $27.85M 40-F · filed 2025-03-20 |
| 2022-12-31 | $17.62M 40-F · filed 2024-04-01 |